Cargando…
Inhibition of myocyte-specific enhancer factor 2A improved diabetic cardiac fibrosis partially by regulating endothelial-to-mesenchymal transition
Cardiac fibrosis is an important pathological process of diabetic cardiomyopathy, the underlying mechanism remains elusive. This study sought to identify whether inhibition of Myocyte enhancer factor 2A (MEF2A) alleviates cardiac fibrosis by partially regulating Endothelial-to-mesenchymal transition...
Autores principales: | Chen, Xue-ying, Lv, Rui-juan, Zhang, Wei, Yan, Yu-gang, Li, Peng, Dong, Wen-qian, Liu, Xue, Liang, Er-shun, Tian, Hong-liang, Lu, Qing-hua, Zhang, Ming-xiang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5058738/ https://www.ncbi.nlm.nih.gov/pubmed/27105518 http://dx.doi.org/10.18632/oncotarget.8842 |
Ejemplares similares
-
Endothelial to mesenchymal transition contributes to arsenic-trioxide-induced cardiac fibrosis
por: Zhang, Yong, et al.
Publicado: (2016) -
Trimetazidine Reduces Cardiac Fibrosis in Rats by Inhibiting NOX2-Mediated Endothelial-to-Mesenchymal Transition
por: Chen, Xingxing, et al.
Publicado: (2022) -
Relaxin inhibits cardiac fibrosis and endothelial–mesenchymal transition via the Notch pathway
por: Zhou, X, et al.
Publicado: (2015) -
Capillarized Liver Sinusoidal Endothelial Cells Undergo Partial Endothelial-Mesenchymal Transition to Actively Deposit Sinusoidal ECM in Liver Fibrosis
por: Ruan, Bai, et al.
Publicado: (2021) -
Roles of TGF-β
Signals in Endothelial-Mesenchymal Transition during Cardiac Fibrosis
por: Yoshimatsu, Yasuhiro, et al.
Publicado: (2011)